GLOBAL MULTIPLEX ASSAY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Multiplex Assay Market, By Product (Consumables, Instruments, and Software), By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays, and Cell-based Multiplex Assays), By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-time PCR, and Other Technologies), By Application (Research & Development, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Metabolism & Endocrinology Disorders, and Other Diseases), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic laboratories, Research & Academic Institutes, and Other End Users), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024
Code : CMI6575
Pages :180
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Companies covered:

Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen, Abcam Plc., Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, MESO SCALE DIAGNOSTICS, LLC., Randox Laboratories Ltd., Seegene Inc, Perkin Elmer Inc., R&D Systems, Inc., and Advanced Cell Diagnostics, Inc.

Top Companies in the Multiplex Assay Market: